TLR 7/8: Covaxin’s Key molecule developed by Indian lab 

  • IASbaba
  • March 2, 2021
  • 0
UPSC Articles
Print Friendly, PDF & Email

TLR 7/8: Covaxin’s Key molecule developed by Indian lab 

Part of: GS Prelims and GS- III – Sci & Tech; Achievements of Indians

In news:

  • The Indian Institute of Chemical Technology (IICT), a Council for Scientific and Industrial Research (CSIR) lab helped in the development of key molecule for COVAXIN. 

Key takeaways 

  • Covaxin is the indigenous vaccine developed by the Bharat Biotech International Limited.
  • It is a highly purified, whole virion, inactivated SARS-Cov-2.
  • It has been formulated with ‘Algel-IMDG’, which contains chemically absorbed TLR7/8 as an adjuvant onto aluminium hydroxide gel to generate the requisite type of immune responses without damaging the body.

Related articles:

Towards an effective vaccination distribution policy

For a dedicated peer group, Motivation & Quick updates, Join our official telegram channel –

Subscribe to our YouTube Channel HERE to watch Explainer Videos, Strategy Sessions, Toppers Talks & many more…

Search now.....

Sign Up To Receive Regular Updates